Non-Alcoholic Steatohepatitis (NASH) Market Upcoming Growth, Key Player Analysis and Forecast 2028

The global Non-Alcoholic Steatohepatitis (NASH) Market was valued at USD 4.57 Billion in 2020 and is projected to reach USD 180.09 Billion by 2028, growing at a CAGR of 58.64%from 2020 to 2028.

The globalNon-Alcoholic Steatohepatitis (NASH) Marketwas valued at USD 4.57 Billion in 2020 and is projected to reach USD 180.09 Billion by 2028, growing at a CAGR of 58.64%from 2020 to 2028. Non-alcoholic steatohepatitis (NASH) is a medical condition in which there is inflammation, as well as damage in the liver caused by the accumulation of fat around the liver. It is part of a group of conditions called NAFLD (non-alcoholic fatty liver disease). Non-alcoholic steatohepatitis (NASH) can get worse and cause scarring of the liver, which leads to cirrhosis. It shows similarity to a kind of liver disorder that is caused by long-term abuse of alcohol. However, it is found in people who drink little or no alcohol.

It is segmented into key regions around the world based on growth rate, share, size, trends, current and emerging factors, production and consumption ratios, industrial chain analysis, demand and supply, import and export, revenue contribution, and key player presence across the globe. To gain a better understanding of the regional spread and progress of theNon-Alcoholic Steatohepatitis (NASH) Market, the report provides a country-by-country analysis of the market.

Request a sample Report ofNon-Alcoholic Steatohepatitis (NASH) Market @

Market Overview:

A growing number of patients are benefiting from cell and gene therapies; previously incurable diseases are finding a cure. Pharmaceutical and healthcare sectors are changing rapidly. With the advent of artificial intelligence (AI) and machine-learning technologies, expectations are rising for more inventive, faster, and less expensive therapeutic development. A data-driven approach could be beneficial to the manufacturing, supply chain, and healthcare ecosystem at large. As a result of increased technology use and data sharing, as well as increased willingness to use prescription and treatment tools, attitudes and behaviors of consumers are changing. Over the next few years, such factors are expected to drive the growth of the pharmaceutical and healthcare markets.

Browse Full Report Description with Research Methodology, Table of Content, and Infographics@

Companies considered and profiled in this market study

The non-alcoholic steatohepatitis (NASH) companies profiled in the report areGenfit, Gilead Sciences,Intercept Pharmaceuticals,Inventiva, Galmed Pharmaceuticals, Tobira Therapeutics, and Allergan.

Segments covered in the report

This report forecasts revenue growth at a global, regional, and country-level while providing an analysis of the industry trends of the sub-segments from 2019-2027. For the purpose of the study, Reports and data have segmented the Global Non-Alcoholic Steatohepatitis (NASH) Market on the basis of disease cause, drug type, end-user, and region:

Disease cause (Revenue USD Million; 2018-2028)

  • Hypertension
  • Heart Disease
  • High blood Lipid
  • Type 2 diabetes
  • Obesity

Drug Type (Revenue, USD Million, 2018-2028)

  • VitaminE Pioglitazone
  • Ocaliva
  • Elafibranor
  • Selonsertib
  • Cencicriviroc
  • Others

End-user Outlook (Revenue, USD; 2018-2028)

  • Hospitals
  • Clinics
  • Homecare Settings

Regional Outlook (Revenue, USD Million; 2018-2028)

  • North America
    • U.S
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • Middle East Africa

Press Release@

Major Points covered in this report are as below:

  • In this report, market development trends and marketing channels in the Non-Alcoholic Steatohepatitis (NASH) Market industry are analyzed, feasibility of new investment projects is evaluated, and overall conclusions are presented.
  • This report provides key industry statistics through tables and figures, serving as an invaluable source of information and advice for companies and individuals involved in this sector.
  • Additionally, this report analyzes development policies and plans, manufacturing processes, and cost structures, as well as import/export consumption figures, supply and demand figures, costs, prices, revenues, and gross margins.
  • For companies and individuals interested in theNon-Alcoholic Steatohepatitis (NASH) Market industry, theNon-Alcoholic Steatohepatitis (NASH) Market report provides information on the current market status of theNon-Alcoholic Steatohepatitis (NASH) Market manufacturers and provides valuable guidance and direction.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report@

Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore More Industry Research by Reports and Data:

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data |
Direct Line: +1-212-710-1370

Read the innovative blog at